Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
REIN-PD: Switching to Levodopa/Carbidopa for ICD in Parkinson's
NCT01683253Phase 4Completed
- Sponsor
- Sandoz
- Start
- Nov 2012
- Primary completion
- Dec 2014
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of levodopa, carbidopa in Parkinson's disease (PD), sponsored by Sandoz. Started Nov 2012; status: completed.
02
Drugs
levodopacarbidopa
03
Conditions
Parkinson's disease (PD)
Beyond the preview
Go deeper on NCT01683253.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01683253.